Searched for
NOVAVAX VACCINES
Two large phase-3 trials of Novavax's COVID-19 vaccine show high levels of protection against infection: Research headSII and Novavax are the key partners in the development and manufacturing of the Novavax vaccine, marketed by Novavax as Nuvaxovid and by S...- Serum Institute gets USFDA nod to export Novavax covid jab to USThe USFDA approval makes SII - the first Indian vaccine maker to export vaccines to the US market, a testimony to the company's abilities t...
- Novavax shares skyrocketed as FDA recommends the Vaccine for Covid19 in the U.SProtein-based covid shot, Novavax has received a recommendation by US Food and drug administration(FDA), which can make it the 4th option f...
- FDA flags heart issues after taking Novavax vaccineIn the company's nearly 30,000 patient trial, conducted between December 2020 and September 2021, there were four cases of myocarditis, a t...
- Covovax approval to strengthen immunization efforts in India, lower and middle income countries, says SIIHe was responding to Union Health Minister Mansukh Mandaviya's announcement that the Central Drug Authority, the Central Drugs Standard Con...
- Novavax says COVID vaccine triggers immune response to Omicron variantNovavax's two-dose, protein-based vaccine was authorized for use this week by European Union regulators and the World Health Organization.
- EU approves 5th COVID-19 vaccine for bloc, one by NovavaxThe Novavax shot joins those from Pfizer-BioNTech, Moderna, Johnson & Johnson and AstraZeneca in the EU's vaccine armory.
- Novavax files for emergency use listing of COVID-19 vaccine with WHOEarlier on Monday, Novavax and its partner Serum Institute of India (SII) had said that they had received the first emergency use authorisa...
- Novovax, Serum Institute seek WHO's approval for their COVID vaccineThe Novavax shots are easier to store and transport than some other options. They've long been expected to play an important role in increa...
- SII aims to launch Covovax by September as US eases suppliesThe Pune-based vaccine maker has received the first lot of supplies of key raw materials for Covovax production, company insiders told ET. ...
- Novavax set for India launch with Serum Institute as manufacturing partnerThe large Novavax trials conducted on 29,960 persons in the US and Mexico have delivered results that equal the Pfizer and Moderna jabs and...
- Novavax: Large study finds COVID-19 shot about 90% effectiveWhile demand for COVID-19 shots in the US has dropped off dramatically, the need for more vaccines around the world remains critical. The N...
- Will meet vaccine delivery goals by second half of 2021: NovavaxSerum Institute, which has signed up to manufacture upto 1 billion doses of Novavax's vaccine, is expected to file for approval in India in...
- Serum’s launch of Novavax shot in India may face delayAdar Poonawalla had complained in the past that the manufacturing of the Novavax vaccine was getting delayed due to a shortage of raw mater...
- Covovax trials begin in India, hope to launch it by Sept 2021: Adar PoonawallaIn August 2020, American vaccine company Novavax, Inc had announced a licence agreement with SII for the development and commercialisation ...
- Novavax hopes ease of storage, pricing will give its vax edgeThe company, which transferred its vaccine technology to Serum Institute of India for distribution in India and middle-income countries, is...
- GAVI inks pact with Serum Institute of India, Novavax for Covid-19 vaccine supplyThe Novavax vaccine has shown 90% efficacy in phase 3 clinical trials in the UK that enrolled more than 15,000 participants aged 18-84 year...
- Booster shot for India: Novavax vaccine shows 90% efficacy, J&J 66%Novavax said its NVX-CoV2373 demonstrated a 90% efficacy in phase 3 trials in the UK, taking it closer to approval by the UK health authori...
- Serum Institute to try out Novavax vaccine in October in partnership with ICMRThe trials of the glycoprotein subunit nanoparticle adjuvanted vaccine developed by Novavax will be led by ICMR-National AIDS Research Inst...
- Novavax aims for 2 bn COVID-19 vaccine doses with expanded India dealU.S. drug developer Novavax Inc said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses ...
Load More
